EXALENZ BIOSCIENCE (Israel) Profile

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:3em;padding-top: 35px;;'>EXE</div>
Analyze Filter   Check how we calculate scores
Equity ratings for EXALENZ BIOSCIENCE are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting October 26, 2019 and ending today January 24, 2020. Click here to learn more.
EXALENZ BIOSCIENCE cannot be verified against its exchange. It appears that EXALENZ BIOSCIENCE is not available for investing at the moment. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

EXALENZ BIOSCIENCE Profile

Exalenz Bioscience Ltd. develops and markets advanced tools for the diagnosing and managing liver and gastroenterology disorders in Israel. Exalenz Bioscience Ltd. is based in Modiin-Maccabim-Reut, Israel. EXALENZ BIOSCIENCE is traded on Tel Aviv Stock Exchange in Israel.. The public information regarding EXALENZ BIOSCIENCE's current market price is not available at this time.
Legal NameEXALENZ BIOSCIENCE
Chairman of the BoardUri GeigerView All
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
EXALENZ BIOSCIENCE (EXEN) is traded on Tel Aviv Stock Exchange in Israel and employs 17 people. The company currently falls under 'Large-Cap' category with current market capitalization of 14.14 B. EXALENZ BIOSCIENCE operates under Healthcare sector and is part of Diagnostics & Research industry. The entity has 27.08 M outstanding shares. EXALENZ BIOSCIENC has accumulated about 2.96 M in cash with (5.99 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11.
Check EXALENZ BIOSCIENCE Probability Of Bankruptcy

EXALENZ BIOSCIENCE Against Markets

EXALENZ BIOSCIENCE cannot be verified against its exchange. It appears that EXALENZ BIOSCIENCE is not available for investing at the moment. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

EXALENZ BIOSCIENCE Corporate Directors

Nachum Shamir Director
Shmuel Rubinstein Director
Saul Yemal External Director
Continue to Investing Opportunities. Please also try Transaction History module to view history of all your transactions and understand their impact on performance.
Company logos by clearbit